Biogen (BIIB) Earnings Date, Estimates & Call Transcripts → They said crypto was dead. It went up 100X. (From InvestorPlace) (Ad) Free BIIB Stock Alerts $219.40 +0.09 (+0.04%) (As of 03/18/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateApr. 23EstimatedActual EPS (Feb. 13) $2.95 Missed By -$0.23 Consensus EPS (Feb. 13) $3.18 Read Call TranscriptListen to Call Get Biogen Earnings AlertsEnter your email address below to receive the latest news and earnings results for BIIB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBIIB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BIIB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. Biogen Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$3.26$4.57$3.70 Q2 20243$3.53$4.11$3.82 Q3 20243$3.64$4.18$3.98 Q4 20243$3.77$3.95$3.86 FY 202412$14.20$16.81$15.36 Q1 20252$3.59$4.46$4.03 Q2 20252$4.18$4.67$4.43 Q3 20252$4.44$5.02$4.73 Q4 20252$4.72$4.83$4.78 FY 20258$16.93$18.98 $17.96BIIB Earnings Date and InformationBiogen last announced its earnings data on February 13th, 2024. The biotechnology company reported $2.95 earnings per share for the quarter, missing analysts' consensus estimates of $3.18 by $0.23. The business earned $2.39 billion during the quarter, compared to analysts' expectations of $2.47 billion. Biogen has generated $7.98 earnings per share over the last year ($7.98 diluted earnings per share) and currently has a price-to-earnings ratio of 27.5. Earnings for Biogen are expected to grow by 15.63% in the coming year, from $15.48 to $17.90 per share. Biogen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 23rd, 2024 based off prior year's report dates.Read More Biogen Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 4/23/2024Estimated)------- 2/13/2024Q4 2023$3.18$2.95($0.23)$4.19$2.47 billion$2.39 billion 11/8/2023Q3 2023$3.99$4.36+$0.37$9.19$2.40 billion$2.53 billion 7/25/2023Q2 2023$3.77$4.02+$0.25$3.97$2.36 billion$2.46 billion 4/25/2023Q1 2023$3.25$3.40+$0.15$4.13$2.34 billion$2.46 billion 2/15/2023Q4 2022$3.48$4.05+$0.57$4.31$2.44 billion$2.54 billion 10/25/2022Q3 2022$4.13$4.77+$0.64$1.70$2.47 billion$2.51 billion Get the Latest News and Ratings for BIIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biogen and its competitors with MarketBeat's FREE daily newsletter. 7/20/2022Q2 2022$4.09$5.25+$1.16$3.26$2.48 billion$2.59 billion 5/3/2022Q1 2022$4.41$3.62($0.79)$5.18$2.50 billion$2.53 billion 2/3/2022Q4 2021$3.32$3.39+$0.07$4.28$2.62 billion$2.73 billion 10/19/2021Q3 2021$4.09$4.77+$0.68$7.32$2.67 billion$2.78 billion 7/21/2021Q2 2021$4.55$5.68+$1.13$8.37$2.61 billion$2.78 billion 4/21/2021Q1 2021$5.06$5.34+$0.28$7.99$2.67 billion$2.69 billion Biogen Earnings - Frequently Asked Questions When is Biogen's earnings date? Biogen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 23rd, 2024 based off last year's report dates. Learn more on BIIB's earnings history. Did Biogen beat their earnings estimates last quarter? In the previous quarter, Biogen (NASDAQ:BIIB) missed the analysts' consensus estimate of $3.18 by $0.23 with a reported earnings per share (EPS) of $2.95. Learn more on analysts' earnings estimate vs. BIIB's actual earnings. How can I listen to Biogen's earnings conference call? The conference call for Biogen's latest earnings report can be listened to online. Listen to Conference Call How can I read Biogen's conference call transcript? The conference call transcript for Biogen's latest earnings report can be read online. Read Transcript How much revenue does Biogen generate each year? Biogen (NASDAQ:BIIB) has a recorded annual revenue of $9.84 billion. How much profit does Biogen generate each year? Biogen (NASDAQ:BIIB) has a recorded net income of $1.16 billion. BIIB has generated $7.98 earnings per share over the last four quarters. What is Biogen's price-to-earnings ratio? Biogen (NASDAQ:BIIB) has a trailing price-to-earnings ratio of 27.49 and a forward price-to-earnings ratio of 14.17. The price/earnings-to-growth ratio is 1.83. What is Biogen's EPS forecast for next year? Biogen's earnings are expected to grow from $15.48 per share to $17.90 per share in the next year, which is a 15.63% increase. More Earnings Resources from MarketBeat Related Companies: American Electric Power Earnings Neurocrine Biosciences Earnings Repligen Earnings Pinnacle West Capital Earnings CRISPR Therapeutics Earnings Portland General Electric Earnings Denali Therapeutics Earnings Gilead Sciences Earnings Moderna Earnings argenx Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earningsBeyond Nvidia: The hidden stars with 200% earnings growth This page (NASDAQ:BIIB) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThe world’s greatest investmentPorter & CompanySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.